Transkaryotic Therapies, Inc.

DUREPLACE

Pharmaceuticals and biologics for use in the treatment of genetic disorders, cancer, hematologic disorders, endocrine disorders, reproductive dysfunction, short stature, diabetes, metabolic disorders, disorders of the central nervous system, gastrointestinal disorders, cardiovascular disorders, autoimmune disorders and other disorders of the immune system, infectious diseases and enzyme deficiency diseases; genetically altered cells and cell lines for use in the production of human therapeutic proteins, for medical diagnostic use, for use in the treatment of a variety of diseases and disorders and for implantation into human patients;Health care services; diagnostic and genetic medical testing services; medical patient monitoring services;

FABRASE

Pharmaceutical preparations for use in the treatment of Fabry's disease;

FABRYTEIN

Pharmaceuticals and biologics for use in the treatment of genetic disorders, cancer, hematologic disorders, endocrine disorders including reproductive dysfunction and metabolic disorders, disorders of the central nervous system, gastrointestinal disorders, cardiovascular disorders, autoimmune disorders and other disorders of the immune system, infectious diseases and enzyme deficiency diseases; genetically altered cells and cell lines for use in the production of human therapeutic proteins, for medical diagnostic use, for use in the treatment of a variety of diseases and disorders and for implantation into human patients;

FABRYTEKT

Pharmaceuticals and biologics for use in the treatment of genetic disorders, cancer, hematologic disorders, endocrine disorders including reproductive dysfunction and metabolic disorders, disorders of the central nervous system, gastrointestinal disorders, cardiovascular disorders, autoimmune disorders and other disorders of the immune system, infectious diseases and enzyme deficiency diseases; genetically altered cells and cell lines for use in the production of human therapeutic proteins, for medical diagnostic use, for use in the treatment of a variety of diseases and disorders and for implantation into human patients;

FAS2T

Educational services, namely, conducting seminars, classes and workshops in the field of pharmaceuticals, disease, health care and health insurance;Providing information and advice to medical patients and to health care professionals regarding health insurance and regarding payments for pharmaceuticals, by telephone, by facsimile transmission and by means of electronic communications networks; making determinations on behalf of patients, insurers and health care professionals whether patients qualify for insurance reimbursement; providing advice and assistance to patients and to health care professionals regarding reimbursement of health care costs from insurers and government agencies; providing advice and assistance to others in obtaining medical treatment authorization from the entities paying for such treatment;Providing health care referrals; providing advice and assistance to patients and to health care professionals regarding obtaining pharmaceutical products from pharmacies or other sources;Providing information and advice regarding pharmaceuticals, disease and health care, by telephone, by facsimile transmission and by means of electronic communications networks; patient advocacy services; providing advice and assistance to patient advocacy organizations;

GA

Pharmaceuticals and biologics for use in the treatment of genetic disorders, cancer, hematologic disorders, endocrine disorders, gastrointestinal disorders, reproductive dysfunction, short stature, diabetes, metabolic disorders, disorders of the central nervous system, autoimmune disorders and other disorders of the immune system, cardiovascular disorders, infectious diseases and enzyme deficiency diseases; genetically altered cells and cell lines for use in the production of human therapeutic proteins, for medical diagnostic use, for use in the treatment of a variety of diseases and disorders and for implantation into human patients;

GA-EPO

Pharmaceuticals and biologics for use in the treatment of genetic disorders, cancer, hematologic disorders, endocrine disorders, gastrointestinal disorders, reproductive dysfunction, short stature, diabetes, metabolic disorders, disorders of the central nervous systems, autoimmune disorders and other disorders of the immune system, cardiovascular disorders, infectious diseases and enzyme deficiency diseases; genetically altered cells and cell lines for use in the production of human therapeutic proteins, for medical diagnostic use, for use in the treatment of a variety of diseases and disorders and for implantation into human patients;GAEPO;

GA-EPO

Product research and development services for others in the field of pharmaceuticals and biologics; consulting services in the field of pharmaceutical and biologic production methods, and in the field of clinical protocols for pharmaceuticals and biologics; scientific research services; health care services; diagnostic and genetic medical testing services; medical patient monitoring services; providing information to others about pharmaceuticals, biologics and health care; intellectual property licensing services in the field of pharmaceuticals and biologics;

HUMAN PROTEINS FOR HUMAN BEINGS

Pharmaceuticals and biologics for use in the treatment of genetic disorders, cancer, hematologic disorders, endocrine disorders, reproductive dysfunction, short stature, diabetes, metabolic disorders, disorders of the central nervous system, gastrointestinal disorders, cardiovascular disorders, autoimmune disorders and other disorders of the immune system, infectious diseases and enzyme deficiency diseases; genetically altered cells and cell lines for use in the production of human therapeutic proteins, for medical diagnostic use, for use in the treatment of a variety of diseases and disorders and for implantation into human patients;Product research and development services for others in the field of pharmaceuticals and biologics; consulting services in the field of pharmaceutical and biologic production methods, and in the field of clinical protocols for pharmaceuticals and biologics; scientific research services; health care services; diagnostic and genetic medical testing services; medical patient monitoring services; providing information to others about pharmaceuticals, biologics and health care; intellectual property licensing services in the field of pharmaceuticals and biologics;

RARE DISEASES, RARE PEOPLE

Product research and development services for others in the field of pharmaceuticals and biologics; consulting services in the field of pharmaceutical and biologic production methods, and in the field of clinical protocols for pharmaceuticals and biologics; scientific research services; health care services; diagnostic and genetic medical testing services; medical patient monitoring services; providing information to others about pharmaceuticals, biologics and health care; intellectual property licensing services in the field of pharmaceuticals and biologics; in Class 42;

REPLASHAY

Pharmaceuticals and biologics for use in the treatment of genetic disorders, cancer, hematologic disorders, endocrine disorders, reproductive dysfunction, short stature, diabetes, metabolic disorders, disorders of the central nervous system, gastrointestinal disorders, cardiovascular disorders, autoimmune disorders and other disorders of the immune system, infectious diseases and enzyme deficiency diseases; genetically altered cells and cell lines for use in the production of human therapeutic proteins, for medical diagnostic use, for use in the treatment of a variety of diseases and disorders and for implantation into human patients;HEALTH CARE SERVICES; DIAGNOSTIC AND GENETIC MEDICAL TESTING SERVICES; MEDICAL PATIENT MONITORING SERVICES;

REPLIDUR

Pharmaceutical preparations for use in the treatment of Hunter's syndrome;

T R A N S K A R Y O T I C

PHARMACEUTICALS AND BIOLOGICS FOR USE IN THE TREATMENT OF GENETIC DISORDERS, CANCER, HEMATOLOGIC DISORDERS, ENDOCRINE DISORDERS, REPRODUCTIVE DYSFUNCTION, SHORT STATURE, DIABETES, METABOLIC DISORDERS, DISORDERS OF THE CENTRAL NERVOUS SYSTEM, GASTROINTESTINAL DISORDERS CARDIOVASCULAR DISORDERS, AUTOIMMUNE DISORDERS AND OTHER DISORDERS OF THE IMMUNE SYSTEM, INFECTIOUS DISEASES AND ENZYME DEFICIENCY DISEASES; GENETICALLY ALTERED CELLS AND CELL LINES FOR USE IN THE PRODUCTION OF HUMAN THERAPEUTIC PROTEINS, FOR MEDICAL DIAGNOSTIC USE, FOR USE IN THE TREATMENT OF A VARIETY OF DISEASES AND DISORDERS AND FOR IMPLANTATION INTO HUMAN PATIENTS;

TKT

Pharmaceutical preparations for use in the treatment of genetic disorders, cancer, hematologic disorders, endocrine disorders, reproductive dysfunction, short stature, diabetes, metabolic disorders, disorders of the central nervous system, gastrointestinal disorders, cardiovascular disorders, autoimmune disorders and other disorders of the immune system, infectious diseases and enzyme deficiency diseases;

TRANSKARYOTIC

Product research and development services for others in the field of pharmaceuticals, biologics and gene therapy; scientific research services; health care services; diagnostic and genetic medical testing services; medical patient monitoring services; providing information to others about pharmaceuticals, biologics, gene therapy and health care; intellectual property licensing services in the field of pharmaceuticals, biologics and gene therapy;

TRANSKARYOTIC THERAPY

Pharmaceuticals and biologics for use in the treatment of genetic disorders, cancer, hematologic disorders, endocrine disorders, reproductive dysfunction, short stature, diabetes, metabolic disorders, disorders of the central nervous system, gastrointestinal disorders, cardiovascular disorders, autoimmune disorders and other disorders of the immune system, infectious diseases and enzyme deficiency diseases; genetically altered cells and cell lines for use in the production of human therapeutic proteins, for medical diagnostic use, for use in the treatment of a variety of diseases and disorders and for implantation into human patients;TRANS KARYOTIC THERAPY;THERAPY;